
ADOPTIVE TRANSFER OF EBV SPECIFIC T-CELLS (EBV-CTL) FOR TREATMENT OF DOCUMENTED EBV LYMPHOMA FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL (HSCT) OR ORGAN TRANSPLANTS (OT): CLINICAL, VIRAL AND IMMUNOLOGIC CORRELATES.
Author(s) -
Ekaterina Doubrovina,
Banu Oflaz-Sozmen,
Nancy A. Kernan,
James W. Young,
Sara J. Abramson,
Juliet N. Barker,
Farid Boulad,
Hugo CastroMalaspina,
Julie TeruyaFeldstein,
Daniel A. Filippa,
Ann A. Jakubowski,
Elena Kanaeva,
Esperanza B. Papadopoulos,
Susan E. Prockop,
Andromachi Scaradavou,
Trudy N. Small,
Richard J. O’Reilly
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-201007272-00740
Subject(s) - ctl* , immunology , lymphoma , adoptive cell transfer , medicine , hematopoietic stem cell transplantation , hematopoietic cell , stem cell , virology , t cell , immune system , haematopoiesis , transplantation , biology , cd8 , genetics